MoneyWorks4Me

Bharat Parenterals - Quaterly Results

20 May 2023 Evaluate
A slight decline in the revenue of Rs. 509.70 millions was seen for the March 2023 quarter as against Rs. 523.10 millions during year-ago period.The Total revenue for the quarter ended March 2023 of  Rs. 92.90  millions  grew by 128.82% from Rs. 40.60 millions.Operating profit for the quarter ended March 2023 rose to 135.50 millions as compared to 66.80 millions of corresponding quarter ended March 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 509.70 523.10 -2.56 2179.80 2120.10 2.82 2179.80 2120.10 2.82
Other Income 69.60 21.40 225.23 188.40 77.80 142.16 188.40 77.80 142.16
PBIDT 135.50 66.80 102.84 402.10 360.00 11.69 402.10 360.00 11.69
Interest 8.00 3.10 158.06 21.90 9.70 125.77 21.90 9.70 125.77
PBDT 127.50 63.70 100.16 380.20 350.30 8.54 380.20 350.30 8.54
Depreciation 14.30 15.60 -8.33 58.50 66.60 -12.16 58.50 66.60 -12.16
PBT 113.20 48.10 135.34 321.70 283.70 13.39 321.70 283.70 13.39
TAX 20.30 7.50 170.67 78.30 70.70 10.75 78.30 70.70 10.75
Deferred Tax -7.30 -7.70 -5.19 -5.70 -9.40 -39.36 -5.70 -9.40 -39.36
PAT 92.90 40.60 128.82 243.40 213.00 14.27 243.40 213.00 14.27
Equity 57.70 57.70 0.00 57.70 57.70 0.00 57.70 57.70 0.00
PBIDTM(%) 26.58 12.77 108.18 18.45 16.98 8.64 18.45 16.98 8.64
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..